Search Results - "Madgula, Vamsi L. M."
-
1
Liquid Chromatography-Tandem Mass Spectrometry Analysis of Urine Specimens for K2 (JWH-018) Metabolites
Published in Journal of analytical toxicology (01-09-2011)“…Marijuana is the most widely used drug of abuse all over the world. The major active constituent of the drug is Δ9-tetrahydrocannabinol (Δ9-THC). Δ9-THC exerts…”
Get full text
Journal Article -
2
Discovery of Potent and Selective A2A Antagonists with Efficacy in Animal Models of Parkinson’s Disease and Depression
Published in ACS medicinal chemistry letters (10-08-2017)“…Adenosine A2A receptor (A2AAdoR) antagonism is a nondopaminergic approach to Parkinson’s disease treatment that is under development. Earlier we had reported…”
Get full text
Journal Article -
3
Intestinal and blood-brain barrier permeability of ginkgolides and bilobalide: in vitro and in vivo approaches
Published in Planta medica (01-04-2010)“…In this study intestinal and blood-brain barrier (BBB) permeability of ginkgolides A, B, C, J and bilobalide, isolated from Ginkgo biloba (Ginkgoaceae), was…”
Get more information
Journal Article -
4
Alkaloids and saponins as cytochrome P450 inhibitors from blue cohosh (Caulophyllum thalictroides) in an in vitro assay
Published in Planta medica (01-03-2009)“…Blue cohosh, Caulophyllum thalictroides (L.) Michx. is a popular herb, roots and rhizomes of which have been extensively used for women's health. Alkaloids and…”
Get more information
Journal Article -
5
Evaluation of separate role of intestine and liver in first pass metabolism of budesonide in rat
Published in Xenobiotica (02-12-2018)“…1. Budesonide, a potent topical corticosteroid, reported to have low oral bioavailability in mice, rat, dog and human due to rapid first pass metabolism…”
Get full text
Journal Article -
6
Discovery of Potent and Selective A 2A Antagonists with Efficacy in Animal Models of Parkinson's Disease and Depression
Published in ACS medicinal chemistry letters (10-08-2017)“…Adenosine A receptor (A AdoR) antagonism is a nondopaminergic approach to Parkinson's disease treatment that is under development. Earlier we had reported the…”
Get full text
Journal Article -
7
Bioavailability, pharmacokinetics, and tissue distribution of the oxypregnane steroidal glycoside P57AS3 (P57) from Hoodia gordonii in mouse model
Published in Planta medica (01-10-2010)“…P57AS3 (P57), an oxypregnane steroidal glycoside, is known to be responsible for the appetite suppressing activity of HOODIA GORDONII, a dietary supplement…”
Get more information
Journal Article -
8
Transport of Schisandra chinensis extract and its biologically-active constituents across Caco-2 cell monolayers - an in-vitro model of intestinal transport
Published in Journal of pharmacy and pharmacology (01-03-2008)“…We have determined the intestinal transport of Schisandra chinensis extract and its lignans (gomisin A, gomisin N and schisandrin C) in the Caco‐2 cell…”
Get full text
Journal Article -
9
Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability
Published in Planta medica (01-04-2007)“…Decursin (DE) and decursinol angelate (DA) were isolated from the roots of Angelica gigas (Apiaceae) and purified by HPLC. DE and DA have been reported to…”
Get more information
Journal Article -
10
In vitro metabolic stability and intestinal transport of P57AS3 (P57) from Hoodia gordonii and its interaction with drug metabolizing enzymes
Published in Planta medica (01-08-2008)“…Hoodia gordonii, a succulent cactus-like plant growing in South Africa, has been used in traditional medicine for its appetite suppressant properties. Its use…”
Get more information
Journal Article